Immunopharmacological and immunotoxicological activities of a water-soluble (1-->3)-beta-D-glucan, CSBG from Candida spp.

[1]  Y. Adachi,et al.  Solubilization of yeast cell-wall beta-(1-->3)-D-glucan by sodium hypochlorite oxidation and dimethyl sulfoxide extraction. , 1999, Carbohydrate research.

[2]  T. Mayadas,et al.  The beta-glucan-binding lectin site of mouse CR3 (CD11b/CD18) and its function in generating a primed state of the receptor that mediates cytotoxic activation in response to iC3b-opsonized target cells. , 1999, Journal of immunology.

[3]  M. Quinn,et al.  Modulation of Endotoxin- and Enterotoxin-Induced Cytokine Release by In Vivo Treatment with β-(1,6)-Branched β-(1,3)-Glucan , 1999, Infection and Immunity.

[4]  D. Melican,et al.  Enhanced clearance of a multiple antibiotic resistant Staphylococcus aureus in rats treated with PGG-glucan is associated with increased leukocyte counts and increased neutrophil oxidative burst activity. , 1998, International journal of immunopharmacology.

[5]  Y. Adachi,et al.  Increases in Hematopoietic Responses Caused by β-Glucans in Mice , 1997 .

[6]  Y. Adachi,et al.  Nitric Oxide Synthesis in Murine Peritoneal Macrophages by Fungal β-Glucans , 1997 .

[7]  N. Ohno,et al.  Subgrouping immunomodulating β‐glucans by monitoring IFN‐γ and NO syntheses , 1997 .

[8]  E. Jones,et al.  The application of various protic acids in the extraction of (1-->3)-beta-D-glucan from Saccharomyces cerevisiae. , 1997, Carbohydrate research.

[9]  V. Vetvicka,et al.  Analysis of the sugar specificity and molecular location of the beta-glucan-binding lectin site of complement receptor type 3 (CD11b/CD18). , 1996, Journal of immunology.

[10]  Y. Adachi,et al.  Enhancement of LPS triggered TNF-alpha (tumor necrosis factor-alpha) production by (1-->3)-beta-D-glucans in mice. , 1995, Biological & pharmaceutical bulletin.

[11]  Y. Adachi,et al.  Enhancement of cytokine production by macrophages stimulated with (1-->3)-beta-D-glucan, grifolan (GRN), isolated from Grifola frondosa. , 1994, Biological & pharmaceutical bulletin.

[12]  E. Jones,et al.  Development of a water-soluble, sulfated (1-->3)-beta-D-glucan biological response modifier derived from Saccharomyces cerevisiae. , 1992, Carbohydrate research.

[13]  K. Saito,et al.  Activation of the complement system by (1----3)-beta-D-glucans having different degrees of branching and different ultrastructures. , 1992, Journal of pharmacobio-dynamics.

[14]  N. Ohno,et al.  Two different conformations of the antitumor beta-D-glucan produced by Sclerotinia sclerotiorum IFO 9395. , 1987, Carbohydrate research.

[15]  Y. Adachi,et al.  Antitumor activity of a beta-1,3-glucan obtained from liquid cultured mycelium of Grifola frondosa. , 1986, Journal of pharmacobio-dynamics.

[16]  N. Ohno,et al.  Structure-function Relationship of antitumor beta-1,3-glucan obtained from matted mycelium of cultured Grifola frondosa. , 1985, Chemical & pharmaceutical bulletin.

[17]  N. Ohno,et al.  Structural characterization and antitumor activity of the extracts from matted mycelium of cultured Grifola frondosa. , 1985, Chemical & pharmaceutical bulletin.

[18]  K. Amemiya,et al.  Cooperative role of T lymphocytes and macrophages in anti-tumor activity of mice pretreated with schizophyllan (SPG). , 1982, The Japanese journal of experimental medicine.

[19]  J. Fachet,et al.  Effect of lentinan on tumor growth in murine allogeneic and syngeneic hosts , 1980, International journal of cancer.

[20]  K. Nitta,et al.  Dependence on chain length of antitumor activity of (1 leads to 3)-beta-D-glucan from Alcaligenes faecalis var. myxogenes, IFO 13140, and its acid-degraded products. , 1978, Cancer research.

[21]  G. Chihara,et al.  Antitumor activity of degraded products of lentinan: its correlation with molecular weight. , 1976, Gan.

[22]  Y. Adachi,et al.  Increase of hematopoietic responses by triple or single helical conformer of an antitumor (1-->3)-beta-D-glucan preparation, Sonifilan, in cyclophosphamide-induced leukopenic mice. , 1999, Bioscience, biotechnology, and biochemistry.

[23]  L. Hokama,et al.  Glucans as immunological adjuvants. , 1995, Advances in experimental medicine and biology.

[24]  M. Ríos-Hernández,et al.  Immunopharmacological studies of beta-1,3-glucan. , 1994, Archives of medical research.

[25]  H. Hojo,et al.  ミドリムシから得たパラミロン,β‐(1→3)‐D‐グルカンのサイトカインに関連した免疫増強活性 , 1992 .

[26]  J. Snick,et al.  Interleukin-6: an overview. , 1990, Annual review of immunology.